Paraneoplastic neuropathies

Current Opinion in Neurology

Volumn 26, Issue 5, 2013, Pages 489-495

  Graus, Francesc ^a   Dalmau, Josep ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN; LENALIDOMIDE; MELPHALAN; RITUXIMAB;

AMYLOIDOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; AUTONOMIC NEUROPATHY; CANCER CHEMOTHERAPY; DEMYELINATING NEUROPATHY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MONOCLONAL IMMUNOGLOBULINEMIA; MOTOR NEUROPATHY; NERVE FIBER DEGENERATION; PARANEOPLASTIC NEUROPATHY; POEMS SYNDROME; REVIEW; SENSORIMOTOR NEUROPATHY; SENSORY NEUROPATHY; VASCULITIS;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEURAL CONDUCTION; PARANEOPLASTIC POLYNEUROPATHY; POEMS SYNDROME; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 84883787263     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328364c020     Document Type: Review

References (69)

1. Henson RA, Urich H. Peripheral neuropathy. In: Henson RA, Urich H, editors. Cancer and the nervous system. Oxford: Blackwell Scientific Publications; 1982. pp. 368-405.
2. Antoine JC, Camdessanché JP. Peripheral nervous system involvement in patients with cancer. Lancet Neurol 2007; 6:75-86.
3. Darnell RB, Posner JB. Dorsal root ganglia and peripheral nerves. In: Gilman S, editor. Paraneoplastic syndromes. Contemporary neurology series 79.
4. Vernino S, Wolfe GI. Antibody testing in peripheral neuropathies. Neurol Clin 2007; 25:29-46.
5. Behin A, Psimaras D, Hoang-Xuan K, Leger JM. Neuropathies in the context of malignancies. Curr Opin Neurol 2008; 21:534-539.
6. Koike H, Tanaka F, Sobue G. Paraneoplastic neuropathy: Wide-ranging clinicopathological manifestations. Curr Opin Neurol 2011; 24:504-510.
7. Giometto B, Vitaliani R, Briani C. Paraneoplastic disorders of the peripheral nervous system. Handb Clin Neurol 2012; 105:865-870.
8. Sharp L, Vernino S. Paraneoplastic neuromuscular disorders. Muscle Nerve 2012; 46:841-850.
9. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75:1135-1140.
10. Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in paraneoplastic syndromes: Report of an EFNS task force. Eur J Neurol 2011; 18:19-27.
11. Roberts WK, Darnell RB. Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 2004; 16:616-622.
12. Graus F, Keime-Guibert F, Reñé R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of 200 patients. Brain 2001; 124:1138-1148.
13. Schold SC, Cho ES, Somasundaram M, Posner JB. Subacute motor neuronopathy: A remote effect of lymphoma. Ann Neurol 1979; 5:271-287.
14. Briani C, Vitaliani R, Grisold W, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology 2011; 76:705-710.
15. Ducray F, Graus F, Vigliani MC, et al. Delayed onset of a second paraneoplastic neurological syndrome in eight patients. J Neurol Neurosurg Psychiatry 2010; 81:937-939.
16. Forsyth PA, Dalmau J, Graus F, et al. Motor neuron syndromes in cancer patients. Ann Neurol 1997; 41:722-730.
17. Distad BJ, Weiss MD. Paraneoplastic motor neuron disease associated with Purkinje cell autoantibody type 1. J Clin Neuromuscul Dis 2010; 12: 36-41.
18. Berghs S, Ferracci F, Maksimova E, et al. Autoimmunity to beta IV spectrin in paraneoplastic lower motor neuron syndrome. Proc Natl Acad Sci U S A 2001; 98:6945-6950.
19. Flanagan EP, Sandroni P, Pittock SJ, et al. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve 2012; 46:823-827.
20. Barua A, Gozzard P, Martin-Ucar AE, Maddison P. Neuronal antibodies and paraneoplastic sensory neuropathy in thymoma. Interact Cardiovasc Thorac Surg 2012; 15:516-517.
21. Graus F, Bonaventura I, Uchuya M, et al. Indolent anti-Hu-associated paraneoplastic sensory neuropathy. Neurology 1994; 44:2258-2261.
22. Oki Y, Koike H, Iijima M, et al. Ataxic vs painful form of paraneoplastic neuropathy. Neurology 2007; 69:564-572.
23. Camdessanché JP, Jousserand G, Franques J, et al. A clinical pattern-based etiological diagnostic strategy for sensory neuronopathies: A French collaborative study. J Peripher Nerv Syst 2012; 17:331-340.
24. Camdessanché JP, Jousserand G, Ferraud K, et al. The pattern and diagnostic criteria of sensory neuronopathy: A case-control study. Brain 2009; 132: 1723-1733.
25. Yu Z, Kryzer TJ, GriesmannGE, et al.CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001; 49:146-154.
26. Antoine JC, Honnorat J, Camdessanché JP, et al. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol 2001; 49:214-221.
27. Saiz A, Dalmau J, Butler MH, et al. Antiamphiphysin I antibodies in patients with paraneoplastic neurologic disorders associated with small cell lung carcinoma. J Neurol Neurosurg Psychiatry 1999; 66:214-217.
28. Molinuevo JL, Graus F, Serrano C, et al. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol 1999; 44:976-980.
29. Wanschitz J, Hainfellner JA, Kristoferitsch W, et al. Ganglionitis in paraneoplastic subacute sensory neuronopathy: A morphologic study. Neurology 1997; 49:1156-1159.
30. Chinn JS, Schuffler MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988; 95:1279-1286.
31. Winston N, Vernino S. Recent advances in autoimmune autonomic ganglionopathy. Curr Opin Neurol 2010; 23:514-518.
32. Koike H, Watanabe H, Sobue G. The spectrum of immune-mediated autonomic neuropathies: Insights from the clinicopathological features. J Neurol Neurosurg Psychiatry 2013; 84:98-106.
33. Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000; 343:847-855.
34. Vernino S, Adamski J, Kryzer TJ, et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998; 50:1806-1813.
35. Storstein A, Vedeler C. Neuropathy and malignancy: A retrospective survey. J Neurol 2001; 248:322-327.
36. Antoine JC, Mosnier JF, Absi L, et al. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without antionconeural antibodies. J Neurol Neurosurg Psychiatry 1999; 67:7-14.
37. Honnorat J, Cartalat-Carel S, Ricard D, et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2009; 80:412-416.
38. Usmani N, Bhatia R, Ikpatt OF, Sharma KR. Diffuse large B-cell lymphoma presenting as Miller-Fisher syndrome. Muscle Nerve 2012; 45:138-143.
39. Rigamonti A, Lauria G, Stanzani L, et al. A case of multifocal motor neuropathy with conduction block associated with gastric and lung adenocarcinoma. J Peripher Nerv Syst 2012; 17:226-228.
40. Vigliani MC, Magistrello M, Polo P, et al. Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study. J Neurol 2004; 251:321-326.
41. Lisak RP, Mitchell M, Zweiman B, et al. Guillain-Barré syndrome and Hodgkin's disease: Three cases with immunological studies. Ann Neurol 1977; 1:72-78.
42. Naveed S, Okoli K, Hollingsworth J, Kasmani R. Guillain-Barré syndrome as a paraneoplastic manifestation of small-cell carcinoma of lung. South Med J 2010; 103:156-158.
43. Antoine JC, Mosnier JF, Lapras J, et al. Chronic inflammatory demyelinating polyneuropathy associated with carcinoma. J Neurol Neurosurg Psychiatry 1996; 60:188-190.
44. Vallat JM, De Mascarel HA, Bordessoule D, et al. Non-Hodgkin malignant lymphomas and peripheral neuropathies-13 cases. Brain 1995; 118:1233-1245.
45. Viala K, Bé hin A, Maisonobe T, et al. Neuropathy in lymphoma: A relationship between the pattern of neuropathy, type of lymphoma and prognosis?. J Neurol Neurosurg Psychiatry 2008; 79:778-782.
46. Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J 2012; 18:463-468.
47. Larue S, Bombelli F, Viala K, et al. Nonanti-MAG DADS neuropathy as a variant of CIDP: Clinical, electrophysiological, laboratory features and response to treatment in 10 cases. Eur J Neurol 2011; 18:899-905.
48. Nobile-Orazio E, Francomano E, Daverio R, et al. Antimyelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. Ann Neurol 1989; 26:543-550.
49. Nobile-Orazio E, Manfredini E, Carpo M, et al. Frequency and clinical correlates of antineural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994; 36:416-424.
50. Viala K, Stojkovic T, Doncker AV, et al. Heterogeneous spectrum of neuropathies in Waldenströ m's macroglobulinemia: A diagnostic strategy to optimize their management. J Peripher Nerv Syst 2012; 17:90-101.
51. Dispenzieri A. POEMS syndrome: Update on diagnosis, risk-stratification, and management. Am J Hematol 2012; 87:804-814.
52. Cui RT, Huang XS, Liu JX, et al. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: Comparison with CIDP. J Clin Neurophysiol 2012; 29:345-348.
53. Nasu S, Misawa S, Sekiguchi Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2012; 83:476-479.
54. Mauermann ML, Sorenson EJ, Dispenzieri A, et al. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. J Neurol Neurosurg Psychiatry 2012; 83:480-486.
55. Oh SJ. Paraneoplastic vasculitis of the peripheral nervous system. Neurol Clin 1997; 15:849-863.
56. Choi HS, Kim DH, Yang SN, et al. A case of paraneoplastic vasculitic neuropathy associated with gastric cancer. Clin Neurol Neurosurg 2013; 115:218-221.
57. Vasku M, Papathemelis T, Maass N, et al. Endometrial carcinoma presenting as vasculitic sensorimotor polyneuropathy. Case Rep Obstet Gynecol 2011; 2011:968756. doi: 10.1155/2011/968756.
58. Zivković SA, Ascherman D, Lacomis D. Vasculitic neuropathy-electrodiagnostic findings and association with malignancies. Acta Neurol Scand 2007; 115:432-436.
59. Matsumuro K, Izumo S, Umehara F, et al. Paraneoplastic vasculitic neuropathy: Immunohistochemical studies on a biopsied nerve and postmortem examination. J Intern Med 1994; 236:225-230.
60. Créange A, Chater A, Brouet JC, et al. A case of POEMS syndrome treated by autologous hematopoietic stem-cell transplantation. Nat Clin Pract Neurol 2008; 4:686-691.
61. Kuwabara S, Misawa S, Kanai K, et al. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome. Neurology 2008; 71:1691-1695.
62. Royer B, Merlusca L, Abraham J, et al. Efficacy of lenalidomide in POEMS syndrome: A retrospective study of 20 patients. Am J Hematol 2013; 88:207-212.
63. Tomá s JF, Giraldo P, Lecumberri R, Nistal S. POEMS syndrome with severe neurological damage clinically recovered with lenalidomide. Haematologica 2012; 97:320-322.
64. Giometto B, Vitaliani R, Lindeck-Pozza E, et al. Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev 2012; 12:CD007625. doi: 10.1002/14651858.CD007625.
65. Antoine JC, Camdessanché JP. Treatment options in paraneoplastic disorders of the peripheral nervous system. Curr Treat Options Neurol 2013; 15:210-213.
66. Keime-Guibert F, Graus F, Broe?t P, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999; 53:1719-1723.
67. Vernino S, O'Neill BP, Marks RS, et al. Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol 2004; 6:55-62.
68. Badari A, Farolino D, Nasser E, et al. A novel approach to paraneoplastic intestinal pseudo-obstruction. Support Care Cancer 2012; 20:425-428.
69. Hollenbeck R, Black BK, Peltier AC, et al. Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma. Arch Neurol 2011; 68:372-377.